U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503808) titled 'A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types' on March 19.
Brief Summary: This is a Phase 1a/1b, open-label, multicenter dose escalation and dose expansion clinical study to evaluate the safety, PK, immunogenicity and preliminary efficacy of IDE034 in participants with locally advanced/metastatic solid tumor types that express B7-H3 and PTK7.
Study Start Date: Feb. 24
Study Type: INTERVENTIONAL
Condition:
Esophageal Squamous Cell Carcinoma
High Grade Serous Ovarian Cancer
Head and Neck Squamous Cell Carcinoma
Colorectal Cancer
Castration-resistant Prostate Cancer
Non Small Cell Lung...